Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Sunitinib × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 20 Lung Neoplasms 9 Small Cell Lung Carcinoma 6 Thymoma 4 Neoplasms 3 Gastrointestinal Stromal Tumors 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Thyroid Neoplasms 1 Thymus Neoplasms 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Somatostatinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pelvic Neoplasms 1 Nervous System Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Mesothelioma 1 Head and Neck Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Brain Neoplasms 1 Adenoma, Islet Cell 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma 1

Interventions

Docetaxel 8 pembrolizumab 7 Pemetrexed 5 Carboplatin 5 Erlotinib Hydrochloride 4 toripalimab 3 Radiosurgery 3 Oxaliplatin 3 Nivolumab 3 Gemcitabine 3 Etoposide 3 Cisplatin 3 Bevacizumab 3 rociletinib 2 lorlatinib 2 fludarabine 2 atezolizumab 2 Vinorelbine 2 Topotecan 2 Radiotherapy 2 Platinum 2 Paclitaxel 2 Itraconazole 2 Irinotecan 2 Interleukin-2 2 Cyclophosphamide 2 Cetuximab 2 vinflunine 1 vandetanib 1 talazoparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02623127 2019-01-23

KOSMIC

Seoul National University Hospital

Phase 2 Completed

Neoplasm Metastasis, Recurrence, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡